Haleon is a consumer health company headquartered in Weybridge, United Kingdom, formed in 2022 through the separation of GSK's consumer healthcare division.
Is this your business? Add your evidence →
Haleon reports comprehensively on Scope 1+2 emissions and has achieved 100% renewable electricity, with verified 55% net reduction versus 2020. Supply chain Scope 3 coverage remains patchy and relies on purchased offsets rather than absolute cuts. Water stewardship is certified across all sites, but TRUE waste certification covers only 46% of facilities. Execution lags commitments: the company achieved just 23% of its planned 2024 operational reduction target.
Haleon scores 50/100 (Making progress) on SINK's independent climate assessment, scored from public data only. Fees pay for the review, never the result. Last verified September 2026.
That places Haleon joint 149th of 847 companies scored, and joint 4th of 19 in Healthcare / Pharmaceuticals.
Where Haleon sits among healthcare / pharmaceuticals peers.
Among the 19 major healthcare / pharmaceuticals brands we've scored, Haleon is tied =4th of 19, with 2 others.
Its three lowest-scoring questions, and what the evidence didn't show.
Scope 3 is estimated, not independently assured.
Scope 1+2 (market-based) declined steadily: 89kt (2022) to 75kt (2023) to 62kt (2024).
Score capped at 6: no independently verified quantified biodiversity footprint or ecosystem restoration demonstrated beyond supply chain.
A score changes when the evidence does. We use new published evidence at the next rescore. Evidence that isn't public can count through an evidence review.
Use this score in tenders
Send the link, or the one-page score sheet. It links back to this page and every source. Free.
Open the score sheet →Add your evidence, £99
Scored low because little is published? Send us your evidence. A person reviews it and your score reflects what you really do. Done within 5 working days.
Evidence review →Go tender-ready, £495 a year
A yearly rescore, a check of up to 25 key suppliers and a score badge for your website (coming soon).
Get in touch →Strongest on Carbon Footprint — Operations and Controversies & Red Flags (8/10, 8/10). Weakest on Carbon Footprint — Supply Chain and Emissions Trajectory (6/10, 6/10).
The 3 companies in the sector scoring nearest above Haleon.
Smith & Nephew reports genuine 63% absolute emissions cuts (Scope 1+2) and 59% Scope 3 reductions since 2021, backed by third-party verification.
See the breakdown →AstraZeneca has cut operational emissions 77.5% since 2015 and locked in science-based net-zero targets, but absolute supply chain emissions are rising 18.6% from baseline.
See the breakdown →GSK has credible climate infrastructure: verified Scope 1&2 data, SBTi-validated net-zero to 2045, and sector-leading nature disclosures.
See the breakdown →The formula and all 12 sources.
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × Scale12 sources used in this assessment. All publicly available. Each row shows which of the ten questions it informed.
“Total Scope 1 & 2 emissions (market-based) (thousands of tonnes CO2e) 89 75 62”
“In 2024, we achieved a 50%* net reduction in our market-based Scope 1 and 2 carbon emissions versus 2020.”
“KPMG LLP has issued independent limited assurance over the selected data indicated using assurance standards ISAE (UK) 3000 and ISAE 3410.”
“We use 100% renewable electricity across our manufacturing sites.”
“2025 TCFD-TNFD disclosures: 2025 Annual Report and Form 20-F, pages 19-30.”
“We also apply Renewable energy Guarantees of Origin (REGOs) based on RE100 guidance.”
“This company received a CDP Forests score of B.”
“A Montreal facility owned by consumer health company Haleon has become Canada's first site to secure status under the Alliance for Water Stewardship (AWS) Standard.”
“The site has not yet evaluated its performance against the targets in the water stewardship plan.”
“This company has a zero or very low Engagement Intensity score on climate policy, and therefore no Organization Score has been assigned.”
“We encourage policymakers to develop enabling policy frameworks to encourage investment in, and adoption of, low and zero carbon technologies.”
“In 2025, our estimated virgin petroleum-based plastic footprint was -9%* compared to our 2022 baseline year.”
If you believe a source has been misread or a newer version exists, submit a challenge.
Haleon is a consumer health company headquartered in Weybridge, United Kingdom, formed in 2022 through the separation of GSK's consumer healthcare division. The group manufactures and markets oral care, vitamins, minerals, pain relief, and digestive health products sold in over 190 countries. It is a significant player in the non-prescription health sector.
One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
No spam. Unsubscribe in one click.
Checking a company?
Search free →Asked to prove you're sustainable?
Get your business scored, free →Been scored?
See what's behind your number →Fees pay for the review, never the result.